{"id":"W4296613255","doi":"10.1016/s2152-2650(22)01064-3","title":"Poster: IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Refractory (planetary science); Follicular lymphoma; Medicine; Oncology; Internal medicine; Follicular phase; Lymphoma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004691813,0.0006200697,0.0006889441,0.0001719207,0.0002735644,0.0006640747,0.0003984625,0.0008485383,0.02166532],"category_scores_gemma":[0.0003743891,0.0001717133,0.0005960905,0.0001055868,0.0002103583,0.0003597612,0.0001713956,0.001753583,0.003853847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003260346,"about_ca_system_score_gemma":0.0003976266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003954577,"about_ca_topic_score_gemma":0.001336938,"domain_scores_codex":[0.9999051,0.00002697236,0.000006037713,0.0000153714,0.00001352644,0.00003301584],"domain_scores_gemma":[0.9998187,0.00003595892,0.00002812678,0.000006606106,0.00001689548,0.00009367468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1962139,0.009516941,0.003991932,0.002283214,0.001105988,0.000656256,0.0001215687,0.0009520918,0.06722113,0.0007433951,0.1832378,0.5339558],"study_design_scores_gemma":[0.3643942,0.2076638,0.0896534,0.00119706,0.003061161,0.003149634,0.0002325489,0.0029419,0.03296699,0.001368073,0.293223,0.0001483099],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8135174,0.06627884,0.002204127,0.02139119,0.00813162,0.00236723,0.007983982,0.001082802,0.07704289],"genre_scores_gemma":[0.9139082,0.01711204,0.00224624,0.01102579,0.004029616,0.0005737785,0.00591765,0.0001076006,0.04507907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02166532,"threshold_uncertainty_score":0.07247764,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02525222596460573,"score_gpt":0.3178122279718731,"score_spread":0.2925600020072673,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}